P130Cas Attenuates Epidermal Growth Factor (EGF) Receptor Internalization by Modulating EGF-Triggered Dynamin Phosphorylation

Abstract

Background

Endocytosis controls localization-specific signal transduction via epidermal growth factor receptor (EGFR), as well as downregulation of that receptor. Extracellular matrix (ECM)-integrin coupling induces formation of macromolecular complexes that include EGFR, integrin, Src kinase and p130Cas, resulting in EGFR activation. In addition, cell adhesion to ECM increases EGFR localization at the cell surface and reduces EGFR internalization. The molecular mechanisms involved are not yet well understood.

Methodology/Principal Findings

We investigated the molecular mechanism by which p130Cas affects the endocytic regulation of EGFR. Biochemical quantification revealed that cell adhesion to fibronectin (FN) increases total EGFR levels and its phosphorylation, and that p130Cas is required for this process. Measurements of Texas Red-labeled EGF uptake and cell surface EGFR revealed that p130Cas overexpression reduces EGF-induced EGFR internalization, while p130Cas depletion enhances it. In addition, both FN-mediated cell adhesion and p130Cas overexpression reduce EGF-stimulated dynamin phosphorylation, which is necessary for EGF-induced EGFR internalization. Coimmunoprecipitation and GST pull-down assays confirmed the interaction between p130Cas and dynamin. Moreover, a SH3-domain-deleted form of p130Cas, which shows diminished binding to dynamin, inhibits dynamin phosphorylation and EGF uptake less effectively than wild-type p130Cas.

Conclusions/Significance

Our results show that p130Cas plays an inhibitory role in EGFR internalization via its interaction with dynamin. Given that the EGFR internalization process determines signaling density and specificity in the EGFR pathway, these findings suggest that the interaction between p130Cas and dynamin may regulate EGFR trafficking and signaling in the same manner as other endocytic regulatory proteins related to EGFR endocytosis.

About the Authors:

Yong Seok Kang

Affiliation: Department of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, Korea

Wook Kim

Affiliation: Diabetes Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America

Yun Hyun Huh

Affiliation: Department of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, Korea

Jeomil Bae

Affiliation: Department of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, Korea

Jin Soo Kim

Affiliation: Department of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, Korea

Woo Keun Song

* E-mail: [email protected]

Affiliation: Department of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, Korea

Introduction

Signaling via the ubiquitously expressed epidermal growth factor receptor (EGFR) is involved in the regulation of cell motility, proliferation, survival and differentiation [1]–[3]. Ligand-dependent asymmetric dimerization of EGFR results in activation of EGFR tyrosine kinase and trans-autophosphorylation [4], [5]. The autophosphorylation sites in the activated EGFR then act as nucleation sites for the formation of specific receptor-signaling protein complexes and downstream kinase (e.g., Erk, Akt) cascades that initiate cell context-specific signaling pathways [6], [7].

EGF ligand induces the translocation of activated EGFRs to clathrin-coated pits and their rapid internalization into early endosomes. Endosomal sorting of EGFRs is followed by lysosomal targeting and receptor degradation. EGFR internalization is therefore thought to be a major pathway via which the receptor is downregulated. Alternatively, endosome-associated EGFRs may continue to interact with compartment-specific signaling proteins. Thus the endocytic trafficking of EGFR determines the duration, intensity and specificity of its signal transduction [8]–[13]. In short, endocytosis likely plays multiple roles in the regulation of signaling via EGFRs.

A large number of regulatory proteins are involved in EGFR internalization and signaling [1], [12], [14]. Dynamin GTPase, one of the critical regulators of endocytic EGFR internalization, catalyzes membrane fission and vesicle budding [15]. Dynamin K44A (Lys44→Ala) mutation, which reduces dynamin GTPase activity, inhibits EGFR internalization and, in turn, increases total EGFR levels. In addition, the K44A dynamin mutant reduces specific tyrosine phosphorylation of EGFR and alters downstream signaling, including signaling by Erk [16], [17]. Knocking down key protein components of clathrin-mediated endocytosis, such as clathrin and AP-2, also affects EGFR signaling activities [13]. In addition, hSef binding to EGFR and Vav2, which interact with Gapvd1, modulates EGFR internalization and trafficking, and also affects EGF signaling [10], [18].

Integrin also regulates EGFR internalization and signaling [19]–[21]. Cell adhesion to fibronectin (FN) induces slight increase of EGFR [21] and formation of macromolecular complexes comprised of EGFR, integrin, p130Cas and Src kinase. Upon complex formation, specific EGFR tyrosine residues, including Tyr 845, are phosphorylated, thereby activating EGFR signaling [20], [21]. In contrast to the internalization of activated EGFRs induced by EGF binding, cell adhesion-induced EGFR activation increases localization of EGFRs at the cell surface [20]. The mechanism by which integrin-EGFR crosstalk attenuates EGFR internalization is not well understood, however.

P130Cas is an adaptor protein participating in cell adhesion, motility and transformation [22], [23]. P130Cas has multiple protein-protein interaction domains, including a SH3-domain, a large tyrosine kinase substrate binding domain (SD), and a Src-binding domain (SBD) [22], [24]–[26]. The SDs are characterized by fifteen tyrosine-Xaa-Xaa-proline (YXXP) motifs that are regarded as major sites of adhesion-dependent phosphorylation [24], [25]. The finding that knocking out p130Cas diminishes adhesion-induced EGFR phosphorylation indicates that p130Cas is a functional mediator of integrin-EGFR crosstalk [20]. Moreover, overexpression p130Cas is, by itself, sufficient to induce ligand-independent EGFR phosphorylation of Tyr 845 [27]. However, the mechanism by which p130Cas contributes to the EGFR signaling pathway remains unclear.

The objective of the present study was to investigate the role of p130Cas in the EGFR internalization pathway. Here we show that p130Cas promotes EGFR activation and increases total EGFR levels under conditions of FN-mediated cell adhesion. In addition, p130Cas inhibits EGF-induced EGFR internalization and dynamin phosphorylation. We also demonstrate that the SH3-domain of p130Cas interacts with the proline-rich domain (PRD) of dynamin, and this interaction is essential for p130Cas-mediated inhibition of dynamin phosphorylation and EGFR internalization.

Results

P130Cas enhances EGFR activation in response to cell adhesion

It is well known that p130Cas is required for cell adhesion-induced EGFR phosphorylation [20], but it was not known whether p130Cas also contributes to cell adhesion-induced increases in EGFR localization at the cell surface. To assess the role of p130Cas in EGFR activation and stabilization at the cell surface induced by cell adhesion, we transfected A431 cells with non-targeting or p130Cas-specific siRNA and examined the effect of knocking down p130Cas. After incubating the transfectants for 60 h, the cells were suspended for 1 h and then plated on FN-coated dishes. Depletion of p130Cas from A431 cells significantly reduced both total EGFR tyrosine phosphorylation (Figure 1A, p-Tyr blot) and EGFR phosphorylation at Tyr 845 (Figure 1A, pEGFR blot). Interestingly, adhesion of control cells to FN elicited a slight increase in total EGFR levels, but adhesion of p130Cas-depleted cells did not.

[Figure omitted. See PDF.]

Figure 1. P130Cas enhances EGFR activation and stabilization at the cells surface in response to cell adhesion.

(A) A431 cells were transfected with non-targeting (siRNA ct) or p130Cas-specific siRNA (siRNA Cas) duplexes and cultured for 60 h. The cells were then serum starved for 12 h, incubated in suspension (Sus) for 1 h, and plated on FN for 0 min, 30 min or 3 h. Tyrosine phosphorylation of EGFR was analyzed by immunoblotting EGFR immunoprecipitates with an anti-phosphotyrosine antibody (pTyr). Right panel: Graphs showing quantification of EGFR phospho-Tyr levels normalized to total EGFR (top) and total EGFR levels normalized to tubulin (bottom). (B) A431 cells were transfected as described above and then serum starved for 12 h, incubated in suspension (Sus) for 1 h and plated on uncoated or FN-coated dishes for 30 min. The cells were then left untreated or treated with EGF (100 ng/ml) for 2 h. Right panel: Graph showing quantification of total EGFR levels normalized to tubulin.

https://doi.org/10.1371/journal.pone.0020125.g001

Given that EGF ligand induces rapid internalization and degradation of EGFRs, we analyzed the effect of p130Cas depletion in the presence of EGF. A431 cells were placed in suspension, and then plated on FN-coated or uncoated culture dishes and treated with 100 ng/ml EGF for 2 h. In control cells, FN-mediated cell adhesion increased total EGFR levels and attenuated EGF-induced EGFR degradation. In p130Cas-depleted cells, by contrast, cell adhesion to FN had no effect on total EGFR levels, and the attenuation of EGFR degradation was abolished (Figure 1B). This suggests that p130Cas plays a regulatory role in EGFR internalization and/or the stable localization of EGFR at the cell surface.

P130Cas negatively regulates internalization and degradation of EGFR

To further examine the role of p130Cas in EGFR internalization, we tested the effect of p130Cas on EGF-induced EGFR internalization and subsequent degradation. After biotinylation of cell surface proteins, we traced the effect of EGF on cell surface levels of EGFR. As shown in figure 2A, treating A431 cells with EGF time-dependently reduced levels of EGFR at the cell surface, which is consistent with earlier reports [28]. Interestingly, knocking down p130Cas significantly accelerated the elimination of biotinylated EGFR from the cell surface, implying rapid induction of EGFR internalization. The degradation rate of total EGFR was also increased by p130Cas depletion.

[Figure omitted. See PDF.]

Figure 2. Depletion of p130Cas enhances EGFR internalization and EGF uptake.

(A) A431 cells were transfected with non-targeting or p130Cas-specific siRNA, cultured for 60 h and then serum starved for 12 h. After treatment with 100 ng/ml EGF for 10 min, 1 h, or 3 h, cell surface proteins were biotinylated and analyzed as described in the Materials and Methods. Right panel: Graph showing quantification of the remaining surface EGFR (top) or total EGFR (bottom) levels after EGF treatment. Data are from 3 independent experiments. (B) A431 cells transfected with non-targeting or p130Cas-specific siRNA were incubate with Texas Red-EGF on ice for 60 min. After washing with ice-cold DMEM, the cells were incubated at 37°C for 15 min to allow internalization. Samples were then visualized by immunofluorescence microscopy, and the images were captured digitally. Representative images are shown; the arrows indicate the stronger Texas Red-EGF signals seen in p130Cas-depeleted cells. Scale bar, 20 µm. Right panel: Box and whisker plots of Texas Red-EGF (TxRed-EGF) intensity. Fifteen images from each group were selected, and the TxRed-EGF intensity in the cell area was analyzed using MetaMorph software. The data are expressed in arbitrary units (A.U). The middle line in each box indicates the median, the top of each box indicates the 75th percentile, the bottom indicates the 25th percentile, the dotted line indicates average, and the whiskers indicate the extent of the 10th and 90th percentiles, respectively. *P<0.05 (Student's t-test).

https://doi.org/10.1371/journal.pone.0020125.g002

We next used Texas Red-conjugated EGF to visually track the EGFR. P130Cas-depleted A431 cells exhibited about 35% greater uptake of Texas Red-EGF than control cells (Figure 2B), while overexpression of exogenous p130Cas dramatically reduced EGF uptake. Cos7 cells overexpressing GFP-Cas exhibited less uptake of Texas Red-EGF than their untransfected neighbor cells and cells transfected with empty GFP vector (Figure 3A). We also assessed the effect of overexpressing GFP-p130Cas in HeLa cells coexpressing moderate levels of EGFR. We found that there was less uptake of Texas Red-EGF into HeLa cells overexpressing GFP-p130Cas than into untransfected control cells, but there was no significant difference between transfected or untransfected cells 120 min after EGF treatment (Figure 3B). Taken together, these findings indicate that p130Cas expression negatively regulates EGF-induced EGFR internalization.

[Figure omitted. See PDF.]

Figure 3. P130Cas overexpression negatively regulates EGF uptake.

(A) Left panels: Representative Cos7 cells transfected with empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) were treated with Texas Red-EGF as described in above. The black lines indicate the transfected cell areas. Scale bars, 20 µm. Right panel: Box and whisker plots of the Texas Red-EGF (TxRed-EGF) intensity per cell. Approximately 40 transfected cells and 50 untransfected neighbour cells were used, and the data are expressed in arbitrary units (A.U). *P>0.3, n.s; not significant, **P<0.05. (B) HeLa cells transfected with empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) were treated with Texas Red-EGF for the indicated times. Top panels: Representative images; black lines indicate the transfected cell areas. Scale bar, 20 µm. Lower panel: Box and whisker plots of the Texas Red-EGF (TxRed-EGF) intensity per cell. At least 20 transfected cells and >50 untransfected neighbor cells from 15 independent images were analyzed at each time point, and the data are expressed in arbitrary units (A.U). *P>0.5, **P<0.001, ***P<0.01, ****P>0.2.

https://doi.org/10.1371/journal.pone.0020125.g003

FN-mediated cell adhesion or p130Cas overexpression reduces EGF-dependent dynamin phosphorylation

Upon EGF binding to EGFR, dynamin GTPase is activated, which promotes the receptor's internalization [29]. To determine the regulatory mechanism by which p130Cas inhibits EGFR internalization and degradation, we tested whether cell adhesion or p130Cas could alter EGF-induced dynamin phospho-activation. Cos7 cells overexpressing GFP- dynamin I were plated on PDL- or FN-coated dishes, with or without EGF treatment. Subsequent immunoprecipitation revealed that EGF treatment leads to phosphorylation of GFP-dynamin I and that the phosphorylation level is higher in cells plated on PDL than on FN, suggesting cell adhesion can alter EGF-induced dynamin phosphorylation (Figure 4A). To address the possibility that p130Cas affects dynamin phosphorylation, we tested the effect of p130Cas overexpression on EGF-induced dynamin I phosphorylation. As shown in figure 4B, levels of GFP-dynamin I phosphorylation were lower in cells overexpressing Myc-tagged p130Cas (Myc-Cas) than in untransfected cells or cells transfected with empty vector.

[Figure omitted. See PDF.]

Figure 4. FN-mediated cell adhesion or p130Cas overexpression reduces EGF-dependent dynamin phosphorylation.

(A) Cos7 cells were transfected with empty vector (GFP-EV) or GFP-dynamin I and then incubated in suspension (Sus) for 1 h and plated on poly-D-lysine (PDL) or fibronectin (FN) for 30 min, with or without 100 ng/ml EGF. GFP-dynamin I immune complexes were generated from the lysate and immunoblotted with antibodies specific to pTyr and GFP (top two blots). In all our experiments, whole cell lysate was also imunoblotted as indicated. A tubulin blot was used as loading control. The dotted box highlights the EGF-induced dynamin phosphorylation. (B) Cos7 cells were transfected with the indicated plasmids and then, after 24 h, were incubated with or without 100 ng/ml EGF. Their lysates were immunoprecipitated with anti-GFP antibody and immunoblotted with anti-pTyr antibody. (C) Cos7 cells were transfected with indicated plasmid set. After 24 h, immunoprecipitation and immunoblotting were carried out as described in (B). (D) A431 cells were transfected with the indicated siRNA and incubated for 60 h. Dynamin II immunocomplexes were precipitated from the lysates and immunoblotted with anti pTyr and anti-dynamin II antibodies. The relative levels of tyrosine phosphorylated dynamin were quantified and normalized with dynamin II level using ImageJ software. The results are depicted in lower panel. WT, wild type; KD, knockdown.

https://doi.org/10.1371/journal.pone.0020125.g004

Because p130Cas is thought to be important transducer of integrin receptor signaling [22], we tested whether FN adhesion and Myc-Cas overexpression exert a synergistic effect on dynamin I phosphorylation. For this analysis, Cos7 cells were transfected with plasmids, as indicated, and then plated on FN, with or without EGF stimulation. The combination of p130Cas overexpression and FN-mediated adhesion dramatically inhibited dynamin I phosphorylation, suggesting integrin-mediated adhesion and p130Cas may act in concert to regulate dynamin I phosphorylation (Figure 4C). To further confirm the role of p130Cas in the regulation of dynamin phosphorylation, we treated p130Cas-depleted A431 cells with EGF and found that tyrosine phosphorylation of endogenous dynamin II was approximately 2-fold increased by EGF treatment in the p130Cas-depleted cells but 1.1-fold in the control cells (p130Cas wild type) (Figure 4D). These results suggest that p130Cas is able to inhibit EGF-induced phospho-activation of dynamin.

The p130Cas SH3-domain interacts with the dynamin Pro-rich domain (PRD)

The existence of p130Cas/dynamin complexes in mammalian tissues was previously demonstrated through coimmunoprecipitation of lysates from the seminiferous tubules and germ cells of adult rats [30]. Bearing that in mind, inhibition of the EGF-induced dynamin phosphorylation by p130Cas prompted us to investigate whether p130Cas interacts with dynamin. Cos7 cells were transiently transfected with GFP-dynamin, with or without a plasmid encoding Myc-Cas. After coimmunoprecipitation, the immunocomplexes were probed for GFP. The result showed that GFP-dynamin I associates with Myc-Cas (Figure 5A) and with endogenous p130Cas (Figure 5B). We then performed coimmunoprecipitation analyses using p130Cas deletion mutants lacking the SH3-domain (Cas ΔSH3) or SD (Cas ΔSD) to identify the p130Cas domain that interacts with dynamin. We found that dynamin primarily bound to the SH3-domain of p130Cas via its PRD (Figure 5C and D). To confirm the direct interaction between p130Cas and dynamin, GST pull-down assays were performed using purified GST-dynamin I PRD and cell lysates from Cos7 cells overexpressing Myc-Cas. As shown in figure 5D, GST-dynamin I PRD was pulled down with Myc-Cas, confirming a specific interaction between p130Cas and the dynamin I PRD.

[Figure omitted. See PDF.]

Figure 5. The SH3-domain of p130Cas interacts with the PRD of dynamin.

(A) Cos7 cells were transfected with the indicated plasmids, incubated for 24 h, and then lysed for immunoprecipitation with anti-GFP antibody. Immunocomplexes were immunoblotted with anti-Myc antibodies. (B) Cos7 cells were transfected with empty vector (GFP-EV) or GFP-dynamin I and the incubated with or without 100 ng/ml EGF for the indicated times. Cell lysates were immunoprecipitated with anti-Cas antibody (Cas2) and immunoblotted with anti-GFP antibody. Whole cell lysate was also imunoblotted with the indicated antibodies. (C) Schematic representation of p130Cas deletion mutants and the results of interacting domain mapping: WT, wild-type; ΔSH3, deletion of SH3-domain; ΔSD, deletion of deletion of the substrate domain; ‘−’ indicates a lack of detectable interaction; ‘+’ indicates interaction. Lower panels: coimmunoprecipitation of a p130Cas deletion mutant and dynamin I. Cos7 cells were transfected with the indicated constructs, and after 24 h the cell lysates were subjected to coimmunoprecipitation analysis with the indicated antibodies. (D) GST pull-down assay verifying the interaction between p130Cas and dynamin. Myc-Cas was pulled down from the lysates of Cos7 transfectants by a GST-dynamin PRD fusion protein immobilized on glutathione beads. The bound proteins were eluted, subjected to SDS-PAGE and immunoblotted using anti-Myc antibody. (E) Cos7 cells were transfected with GFP-p130Cas (GFP-Cas) and mRFP-dynamin I. After 24 h, the cells were prepared for immunofluorescence analysis as described in the Materials and Methods. The boxed areas are enlarged in the insets.

https://doi.org/10.1371/journal.pone.0020125.g005

To further confirm p130Cas-dynamin interaction, we tested whether p130Cas colocalizes with dynamin. After EGF treatment, transiently expressed GFP-Cas and mRFP-dynamin I were readily colocalized near cell edge (Figure 5E, arrows). Similar pattern of co-localization was previously demonstrated by cortactin, a well-characterized binding partner of dynamin [31]. It thus appears that p130Cas can associate with dynamin, and that the p130Cas SH3-domain mediates binding to the dynamin PRD.

Deletion of the p130Cas SH3-domain restores EGF-induced dynamin phosphorylation and EGF internalization

Given that p130Cas negatively regulates EGF-induced dynamin phosphorylation and EGFR internalization (Figures 2, 3, 4), we set out to determine the function of the p130Cas-dynamin interaction during dynamin phosphorylation and EGFR internalization. Cos7 cells were cotransfected with GFP-dynamin I and wild-type p130Cas or Cas ΔSH3, after which GFP-dynamin I was immunoprecipitated in the presence or absence of EGF, and the precipitate was immunoblotted with anti-phospho-tyrosine antibody (pTyr). Introduction of wild-type p130Cas into cells reduced EGF-induced dynamin phosphorylation, and overexpression of Cas ΔSH3 restored EGF-induced dynamin phosphorylation to control levels (Figure 6A). Because dynamin phosphorylation directly affected EGFR internalization, we investigated the effect of Cas ΔSH3 on EGF uptake and found that EGF uptake was significantly inhibited by overexpression of p130Cas (Figures 2 and 3). As expected, the inhibition was abolished in the cells expressing Cas ΔSH3, which is unable to interact with the dynamin PRD (Figure 6B). This suggests that the p130Cas-dynamin interaction is required for the inhibitory effect of p130Cas on EGF-triggered dynamin activation and subsequent EGFR internalization.

[Figure omitted. See PDF.]

Figure 6. Deletion of the p130Cas-SH3 domain restores EGF-induced dynamin phosphorylation and EGF internalization.

(A) Cos7 cells transfected with the indicated plasmids were incubated with or without 100 ng/ml EGF, after which their lysates were immunoprecipitated with anti-GFP antibody and immunoblotted with anti-pTyr and anti-GFP antibodies. Whole cell lysate was also imunoblotted with the indicated antibodies. ΔSH3, deletion of SH3-domain, Lower panel: Graph showing levels of tyrosine phosphorylation of GFP-dynamin I normalized to tubulin. (B) Cos7 cells were transfected with empty vector (Myc-EV), wild-type Myc-p130Cas (Myc-Cas), Myc-p130Cas SH3-domain deletion mutant (Myc-Cas ΔSH3) or Myc-p130Cas SD deletion mutant (Myc-Cas ΔSD) and then treated with Texas Red-EGF as described as above. Upper panels: Representative images; black lines indicates the transfected cell areas. Scale bars, 20 µm. Lower panel: Box and whisker plots of Texas Red-EGF (TxRed-EGF) intensity per cell. For each condition, 37–120 transfected cells and 90–146 untransfected neighbor cells were assessed, and the data are expressed in arbitrary units (A.U). *P>0.2, **P<0.001. (C) HeLa cells transfected with empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) were treated with Texas Red-transferrin (TxRed-Tfn) as described above. Left panels: Representative images; black lines indicate the transfected cell areas. Scale bars, 10 µm. Right panel: Box and whisker plots of Texas Red- transferrin intensity per cell. Approximately 20 transfected cells and 40 untransfected neighbor cells were used, and the data are expressed in arbitrary units (A.U). *P>0.2, **P<0.005.

https://doi.org/10.1371/journal.pone.0020125.g006

Discussion

P130Cas is a well-characterized adaptor/scaffold protein that plays a key role in mediating integrin signaling and regulating extracellular matrix (ECM)-dependent cell migration and cell transformation [22]–[24]. There have been several reports that p130Cas is important for formation of integrin-EGFR complexes, and for modulation of EGF signaling in response to ECM stimuli [20], [22]. In the present study, we demonstrated that p130Cas is also required for FN-dependent EGFR phosphorylation, without stimulation by EGF, and for increases in total EGFR levels stimulated by FN-mediated cell adhesion. In addition, p130Cas tends to stabilize EGFR at the cell surface, even in the presence of EGF. Overexpression of p130Cas in Cos7 and HeLa cells delayed EGFR internalization, as indicated by EGF uptake assays. Conversely, knocking down p130Cas using siRNA in A431 cells enhanced EGFR internalization. To identify the mechanism by which p130Cas negatively regulates EGFR internalization and degradation, we assessed the relation between the activities of p130Cas and dynamin GTPase. We found that p130Cas acting in association with dynamin is able to downregulate EGF-induced dynamin phosphorylation and, in turn, reduce dynamin activity. The novel role of p130Cas in regulating EGFR endocytosis and dynamin activity provides new mechanistic insight into cell adhesion-dependent regulation of EGF signaling.

It was previously shown that ligand activated EGFRs are rapidly internalized and, through endosomal trafficking, are targeted to lysosomal degradation [2], [11], [32]. By contrast, EGFR activation through integrin-mediated cell adhesion tends to reduce EGFR internalization and to increase EGFR levels at the cell surface. Moreover, it was previously reported that p130Cas plays an essential role in cell adhesion-induced EGFR activation [20]. We therefore hypothesized that, like FN-mediated adhesion, p130Cas may contribute to EGFR stabilization at the cell surface. Consistent with that notion, knocking down p130Cas attenuated cell adhesion-mediated EGFR activation as well as adhesion-induced increases in total EGFR levels without influencing EGFR expression (Figure 1B and data not shown). Furthermore, knockdown of p130Cas enhanced EGF-induced EGFR internalization and degradation, while overexpression of p130Cas inhibited EGF uptake, indicating that EGFR internalization is likely regulated by p130Cas (Figure 2 and 3). Given that Neu (also known as ErbB2, Her2) associates with the cell surface EGFR at an early time point after EGF treatment [8], it is interesting to note that depletion of p130Cas in A431 cells dramatically reduced EGFR/Neu dimerization by EGF (Figure S1A).

Previous studies established that proteins regulating EGFR endocytosis can also affect downstream signaling by EGF [14]. For example, hSef overexpression attenuates EGFR degradation and promotes activity in the EGF-triggered Erk pathway [10]. Exogenous Vav2 expression also delays EGFR internalization and stabilizes EGFR at the cell surface, leading to enhanced phosphorylation of EGFR, Erk and Akt [18]. In accordance with previous reports, overexpression of p130Cas in Cos7 cells clearly led to phosphorylation of EGFR and Akt (Figure S1B and C), indicating that p130Cas is able to modulate downstream signaling of EGF as well. However, phosphorylation of Erk, a downstream mediator of EGFR signaling, was unaffected by changes in the p130Cas levels (overexpression or knockdown). This likely reflects the complexity and/or the diversity of the Erk activation pathway in different cell types and signaling contexts. [19], [33].

EGFR internalization is regulated by several mechanisms, including specific ligand binding, EGFR ubiquitination, the binding of the endocytic machinery to EGFR and the participation of other accessory proteins [11], [12], [28], [32], [34]. Src is well established as an endocytosis regulator required for efficient receptor internalization [35]. EGF treatment increases Src-dependent phosphorylation of dynamin, which leads to EGFR internalization and degradation [29]. On the other hand, it is noteworthy that both FN-mediated cell adhesion and the Src-binding domain of p130Cas are able to transiently activate Src kinase [36]–[38], nevertheless ectopic expression of p130Cas together with FN-mediated cell adhesion reduced EGF-induced phosphorylation of dynamin (Figure 4). Thus the mechanism by which integrin-EGFR crosstalk and p130Cas attenuates EGFR internalization may involve differential regulation of Src kinase activity.

Given that the dynamin PRD is a potential target for numerous proteins containing an SH3-domain [15], it seems plausible that p130Cas reduces dynamin phosphorylation by binding to dynamin, thereby interrupting the dynamin-Src association needed for the reaction. This idea is supported by the observation that a p130Cas mutant lacking the SH3-domain (Cas ΔSH3) could not interact with dynamin, nor could it inhibit EGF uptake (Figure 5 and 6). However, it remains to be determined whether p130Cas-mediated inhibition is achieved through interference with the Src-dynamin interaction, or whether p130Cas activity leads to a reduction in dynamin GTPase activity and self-assembly.

Src-dependent phospho-activation of dynamin is a crucial step for several receptor proteins such as β2-adrenergic receptor, transferrin receptor as well as EGFR. [29], [39], [40]. It is therefore possible that p130Cas affects the internalization of other receptors in addition to EGFR. Indeed, we observed that depletion of p130Cas from HeLa cells increased Texas Red-transferrin uptake (Figure 6C). It would be interesting to know whether p130Cas is a common regulator of internalization of a wide spectrum of receptors through its inhibition of receptor-mediated elevation in dynamin activity.

In summary, this work outlines the inhibitory role of p130Cas in EGFR internalization and EGF-stimulated dynamin activation, and provides evidence that p130Cas stabilizes EGFR at the cell surface, thereby regulating its downstream signaling.

Materials and Methods

Ethics Statement

All animal experiments were approved by the Gwangju Institute of Science and Technology Animal Care and Use Committee (the permit number: GIST-2008-35).

Materials

Rabbit anti-phospho-EGFR (Tyr 845), rabbit anti-phospho-Akt (Ser473), mouse anti-phospho-Erk, rabbit anti-EGFR, goat anti-dynamin II and rabbit anti-Neu antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-phospho-p130Cas (Tyr 165) was from Cell Signaling Technology (Beverly, MA, USA). Mouse monoclonal anti-p130Cas (Clone 21) was from BD Biosciences (San Jose, CA, USA). Mouse monoclonal anti-phospho-Tyr (clone 4G10) and mouse monoclonal anti-dynamin I (Hudy 1) were from Upstate Biotechnology (Lake Placid, NY, USA). Mouse monoclonal anti-tubulin was from Sigma (St Louis, MO, USA). Rabbit anti-GFP antibody was generated by immunizing New Zealand White rabbits with the GST-GFP protein and then purified. Mouse monoclonal anti-Myc (clone 9E10) antibody was generated from mouse ascites after hybridoma injection. Rabbit anti-p130Cas (Cas2) was a gift from Dr. Hismaru Hirai (University of Tokyo) [41]. Texas Red-conjugated EGF was from Molecular Probes (Eugene, OR, USA), and Texas Red-conjugated transferrin and recombinant EGF were from Invitrogen (Carlsbad, CA, USA). Human FN and synthetic poly-D-lysine (PDL) were from Sigma (St Louis, MO, USA).

Cell culture and transfections

Cos7 and HeLa cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA), and A431 cells from the Korean Cell Line Bank (KCLB, Seoul, Korea). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Hyclone). Cell culture plates were coated with 20 µg/ml FN or 75 µg/ml PDL as needed. Cover slips were coated with 0.2% gelatin before cell plating.

pGEX4T1 dynamin I PRD, pEGFP dynamin I and pEGFP dynamin II constructs were generously provided by Dr. Sunghoe Chang (Seoul National University College of Medicine). mRFP-dynamin I was a gift from Dr. Pietro DeCamilli (Yale University). pEGFP p130Cas [42], Myc-tagged pcDNA3 wild-type and mutant p130Cas plasmids were described earlier [43]. All transfections were carried out using Lipofectamine (Invitrogen, Carlsbad, CA, USA) or GeneExpresso 8000 (InnoVita, Gaithersburg, MD, USA) according to the manufacturer's instructions.

Cells were depleted of p130Cas using siRNA corresponding to nucleotides 2366–2384 (CCCACAAGCUGGUGUUACU dTdT) of p130Cas [44] (Bioneer, Daejeon, Korea). Transfection of control (nonsilencing fluorescein-labeled siRNA duplex; Bioneer) or anti-p130Cas siRNA was performed in Opti-MEM I medium (Invitrogen) using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. The transfection efficiency for the siRNAs, as determined from images of fluorescein-labeled siRNA duplex, was consistently >95%.

For cell adhesion assays, Cos7 and HeLa cells were serum starved for 12 h, and A431 cells were serum starved 24 h, after which they were detached and replated on culture dishes coated with FN or PDL. The cells were then incubated with or without 100 ng/ml EGF in DMEM for the indicated times. EGF-induced dynamin phosphorylation was performed as described previously [29]. Briefly, cells transiently expressing GFP-dynamin I were serum-starved for 12 h and then pretreated with 100 µM Na3VO4 for 1 h followed by treatment with 100 ng/ml EGF for an additional 30 min. For Texas Red-EGF and Texas Red-transferrin uptake assays, the cells were serum starved as above, after which they were chilled, washed with cold PBS and incubated with 1 µg/ml Texas Red EGF or 25 µg/ml Texas Red-transferrin for 1 h at 4°C. After washing away the unbound ligand, the cells were rapidly warmed to 37°C for 15 min before being fixed for immunofluorescence analysis.

Immunoprecipitation and Immunoblotting

Twenty-four hours after plasmid transfection or 60 h after siRNA transfection, the cells were manipulated as described above and then lysed in modified radioimmunoprecipitation assay buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 10 mM NaF, 1 mM PMSF, 1 mM Na3VO4, 10 µM leupeptin, 1.5 µM pepstatin, and 10 µg/ml aprotinin). The lysates were cleared by centrifugation at 12,000 r.p.m for 10 min at 4°C, after which the appropriate antibody was added to the supernatant and incubated for 4 h or overnight at 4°C. The resultant immune complexes were precipitated with protein A or G-Sepharose (GE Healthcare, Piscataway, NJ, USA) for 3 h. The beads were then washed four times with lysis buffer, suspended in SDS sample buffer, boiled for 10 min, resolved by SDS-PAGE and analyzed by immunoblotting as described previously [45]. Tyrosine phosphorylation of EGFR was analyzed by immunoprecipitation with anti-EGFR antibody, followed by immunoblotting with anti-phospho-Tyr antibody. Phosphorylation of GFP-anti-dynamin I and endogenous dynamin II was detected by immunoprecipitation with anti-GFP or dynamin II antibody, followed by immunoblotting with anti-phospho-Tyr antibody. For analysis of the interaction of GFP-dynamin with wild-type or mutant Myc-p130Cas, the lysates were immunoprecipitated with anti-GFP followed by immunoblotting with anti-Myc antibody. Interaction of GFP-dynamin with endogenous p130Cas was analyzed by immunoprecipitation with anti-p130Cas antibody followed by immunoblotting with anti-GFP antibody. The resultant band intensities were measured using ImageJ software (Ver. 1.43u, NIH, Bethesda, USA).

EGFR internalization assay

Cells transfected with siRNA or plasmid DNA were serum starved for 12 h and treated with EGF-containing DMEM, as indicated. They were then washed three times with cold PBS and incubated with 0.5 mg/ml Sulfo-NHS-SS-Biotin (Thermo Scientific, Waltham, MA, USA) in a borate buffer (10 mM boric acid, 150 mM NaCl, pH 8.0) for 1 h at 4°C with gentle shaking. The reaction was quenched by adding ice-cold PBS containing 15 mM glycine, after which the cells were washed with cold PBS, lysed and precipitated using streptavidin-agarose resin (Thermo Scientific, Waltham, MA, USA). The precipitates were then immunoblotted with anti-EGFR antibody to detect cell surface EGFR. P130Cas blots served as a negative control of membrane protein biotinylation. Aliquots of cell lysate were taken before the incubation with streptavidin-agarose and analyzed by immunoblotting using the indicated antibodies.

Immunofluorescence

To detect Texas Red-EGF, GFP-p130Cas, mRFP-dynamin or Myc-p130Cas, the cells were treated as described in the figure legends, fixed, permeabilized, blocked, incubated with the appropriate primary antibody, and stained with Alexa Fluor-conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA). Immunohistochemical detection of Myc-p130Cas protein was carried out using anti-Myc (clone 9E10) as the primary antibody, and nuclei were labeled with Hoechst dye 33258 (Sigma, St Louis, MO, USA). Images were obtained using an Olympus confocal microscope FV1000 (Olympus, Tokyo, Japan) using FV10-MSASW software or a Leica DMR upright fluorescence microscope (Leica Microsystems, Wetzlar, Germany) driven by MetaMorph imaging software (Ver. 6.3r6, Molecular Devices, Sunnyvale, CA). Fluorescence intensities within cells were measured using MetaMorph Offline image analysis software (Ver. 7.6.0.0, Molecular Devices, Sunnyvale, CA).

GST pull-down assay

GST or GST-dynamin I PRD was expressed in Escherichia coli and purified through adsorption onto glutathione-Sepharose 4B beads (GE Healthcare, Piscataway, NJ, USA). Cell lysates were prepared from Cos7 cells expressing Myc-Cas or Myc-only empty vector using the modified radioimmunoprecipitation assay buffer described above. Aliquots (2 mg) of cell lysate were incubated with GST or GST-dynamin I PRD in binding buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Tween 20, 1 mM EDTA, 2.5 mM EGTA, 10% glycerol, 1 mM dithiothreitol, 0.1 mM Na3VO4, 1 mM PMSF, and protease inhibitors), after which the beads were extensively washed in the same buffer, and the adsorbed proteins were separated by SDS-polyacrylamide gel electrophoresis and visualized by immunoblotting with anti-Myc antibody.

Supporting Information

[Figure omitted. See PDF.]

Figure S1.

P130Cas modulates EGFR signaling differentially depending on the cell type. (A) P130Cas depletion reduces Neu-EGFR association in A431 cells. Depletion of p130Cas from A431 cells alters EGF-induced EGFR signaling (e.g., Neu-EGFR dimerization) [8], [46]. A431 cells transfected with non-targeting or p130Cas-specific siRNA were serum starved or stimulated with EGF (100 ng/ml) for 60 min at 4°C and then warmed for 10 min at 37°C. Cell lysates were used for immunoprecipitation or immunoblot analysis with the indicated antibodies. (B) FN-mediated cell adhesion increases phosphorylation of EGFR, Akt and Erk. Cos7 cells were incubated in suspension (Sus) for 1 h and plated on FN for 30 min or 3 h. They were then lysed, subjected to SDS-PAGE and immunoblotted using the indicated antibodies. In all of our experiments, whole cell lysate was also imunoblotted as indicated, and tubulin was used as a loading control. (C) Overexpression of p130Cas enhances FN-induced phosphorylation of EGFR and Akt, but not Erk. Cos7 cells were transfected with empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) and treated as described in (B).

https://doi.org/10.1371/journal.pone.0020125.s001

(TIF)

Acknowledgments

We are grateful to Dr. Ryuichi Sakai for providing rabbit anti-Cas antibody. We thank Dr. Pietro DeCamilli for providing mRFP-dynamin I and Dr Sunghoe Chang for providing dynamin constructs.

Author Contributions

Conceived and designed the experiments: YSK JSK WK WKS. Performed the experiments: YSK JSK. Analyzed the data: YSK YHH JB. Contributed reagents/materials/analysis tools: YSK JB. Wrote the paper: YSK YHH WKS.

Citation: Kang YS, Kim W, Huh YH, Bae J, Kim JS, Song WK (2011) P130Cas Attenuates Epidermal Growth Factor (EGF) Receptor Internalization by Modulating EGF-Triggered Dynamin Phosphorylation. PLoS ONE6(5): e20125. https://doi.org/10.1371/journal.pone.0020125

References

1. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, et al. (2006) The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 1766: 120–139.S. SebastianJ. SettlemanSJ ReshkinA. AzzaritiA. Bellizzi2006The complexity of targeting EGFR signalling in cancer: from expression to turnover.Biochim Biophys Acta1766120139

2. Linggi B, Carpenter G (2006) ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 16: 649–656.B. LinggiG. Carpenter2006ErbB receptors: new insights on mechanisms and biology.Trends Cell Biol16649656

3. Wheeler DL, Dunn EF, Harari PM (2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493–507.DL WheelerEF DunnPM Harari2010Understanding resistance to EGFR inhibitors-impact on future treatment strategies.Nat Rev Clin Oncol7493507

4. Jura N, Endres NF, Engel K, Deindl S, Das R, et al. (2009) Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137: 1293–1307.N. JuraNF EndresK. EngelS. DeindlR. Das2009Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.Cell13712931307

5. Wang Y, Pennock S, Chen X, Wang Z (2002) Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol 22: 7279–7290.Y. WangS. PennockX. ChenZ. Wang2002Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.Mol Cell Biol2272797290

6. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341–354.NE HynesHA Lane2005ERBB receptors and cancer: the complexity of targeted inhibitors.Nat Rev Cancer5341354

7. Nyati MK, Morgan MA, Feng FY, Lawrence TS (2006) Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer 6: 876–885.MK NyatiMA MorganFY FengTS Lawrence2006Integration of EGFR inhibitors with radiochemotherapy.Nat Rev Cancer6876885

8. Burke P, Schooler K, Wiley HS (2001) Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 12: 1897–1910.P. BurkeK. SchoolerHS Wiley2001Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.Mol Biol Cell1218971910

9. Kim HJ, Taylor LJ, Bar-Sagi D (2007) Spatial regulation of EGFR signaling by Sprouty2. Curr Biol 17: 455–461.HJ KimLJ TaylorD. Bar-Sagi2007Spatial regulation of EGFR signaling by Sprouty2.Curr Biol17455461

10. Ren Y, Cheng L, Rong Z, Li Z, Li Y, et al. (2008) hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation. Cell Signal 20: 518–533.Y. RenL. ChengZ. RongZ. LiY. Li2008hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation.Cell Signal20518533

11. Goh LK, Huang F, Kim W, Gygi S, Sorkin A (2010) Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 189: 871–883.LK GohF. HuangW. KimS. GygiA. Sorkin2010Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor.J Cell Biol189871883

12. Roepstorff K, Grandal MV, Henriksen L, Knudsen SL, Lerdrup M, et al. (2009) Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 10: 1115–1127.K. RoepstorffMV GrandalL. HenriksenSL KnudsenM. Lerdrup2009Differential effects of EGFR ligands on endocytic sorting of the receptor.Traffic1011151127

13. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, et al. (2008) Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 15: 209–219.S. SigismundE. ArgenzioD. TosoniE. CavallaroS. Polo2008Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.Dev Cell15209219

14. Sorkin A, von Zastrow M (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10: 609–622.A. SorkinM. von Zastrow2009Endocytosis and signalling: intertwining molecular networks.Nat Rev Mol Cell Biol10609622

15. Praefcke GJ, McMahon HT (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5: 133–147.GJ PraefckeHT McMahon2004The dynamin superfamily: universal membrane tubulation and fission molecules?Nat Rev Mol Cell Biol5133147

16. Johannessen LE, Haugen KE, ostvold AC, Stang E, Madshus IH (2001) Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms. Biochem J 356: 87–96.LE JohannessenKE HaugenAC ostvoldE. StangIH Madshus2001Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.Biochem J3568796

17. Kranenburg O, Verlaan I, Moolenaar WH (1999) Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase. J Biol Chem 274: 35301–35304.O. KranenburgI. VerlaanWH Moolenaar1999Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase.J Biol Chem2743530135304

18. Thalappilly S, Soubeyran P, Iovanna JL, Dusetti NJ (2010) VAV2 regulates epidermal growth factor receptor endocytosis and degradation. Oncogene 29: 2528–2539.S. ThalappillyP. SoubeyranJL IovannaNJ Dusetti2010VAV2 regulates epidermal growth factor receptor endocytosis and degradation.Oncogene2925282539

19. Comoglio PM, Boccaccio C, Trusolino L (2003) Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 15: 565–571.PM ComoglioC. BoccaccioL. Trusolino2003Interactions between growth factor receptors and adhesion molecules: breaking the rules.Curr Opin Cell Biol15565571

20. Moro L, Dolce L, Cabodi S, Bergatto E, Erba EB, et al. (2002) Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 277: 9405–9414.L. MoroL. DolceS. CabodiE. BergattoEB Erba2002Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines.J Biol Chem27794059414

21. Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, et al. (2004) Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol 24: 8586–8599.HM BillB. KnudsenSL MooresSK MuthuswamyVR Rao2004Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells.Mol Cell Biol2485868599

22. Defilippi P, Di Stefano P, Cabodi S (2006) p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16: 257–263.P. DefilippiP. Di StefanoS. Cabodi2006p130Cas: a versatile scaffold in signaling networks.Trends Cell Biol16257263

23. Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P (2010) Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 10: 858–870.S. CabodiM. del Pilar Camacho-LealP. Di StefanoP. Defilippi2010Integrin signalling adaptors: not only figurants in the cancer story.Nat Rev Cancer10858870

24. Bouton AH, Riggins RB, Bruce-Staskal PJ (2001) Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20: 6448–6458.AH BoutonRB RigginsPJ Bruce-Staskal2001Functions of the adapter protein Cas: signal convergence and the determination of cellular responses.Oncogene2064486458

25. Shin NY, Dise RS, Schneider-Mergener J, Ritchie MD, Kilkenny DM, et al. (2004) Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration. J Biol Chem 279: 38331–38337.NY ShinRS DiseJ. Schneider-MergenerMD RitchieDM Kilkenny2004Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration.J Biol Chem2793833138337

26. Meenderink LM, Ryzhova LM, Donato DM, Gochberg DF, Kaverina I, et al. (2010) P130Cas Src-binding and substrate domains have distinct roles in sustaining focal adhesion disassembly and promoting cell migration. PLoS One 5: e13412.LM MeenderinkLM RyzhovaDM DonatoDF GochbergI. Kaverina2010P130Cas Src-binding and substrate domains have distinct roles in sustaining focal adhesion disassembly and promoting cell migration.PLoS One5e13412

27. Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, et al. (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66: 7007–7015.RB RigginsKS ThomasHQ TaJ. WenRJ Davis2006Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.Cancer Res6670077015

28. Liu NS, Loo LS, Loh E, Seet LF, Hong W (2009) Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor. Embo J 28: 3485–3499.NS LiuLS LooE. LohLF SeetW. Hong2009Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor.Embo J2834853499

29. Ahn S, Kim J, Lucaveche CL, Reedy MC, Luttrell LM, et al. (2002) Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor. J Biol Chem 277: 26642–26651.S. AhnJ. KimCL LucavecheMC ReedyLM Luttrell2002Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor.J Biol Chem2772664226651

30. Lie PP, Xia W, Wang CQ, Mruk DD, Yan HH, et al. (2006) Dynamin II interacts with the cadherin- and occludin-based protein complexes at the blood-testis barrier in adult rat testes. J Endocrinol 191: 571–586.PP LieW. XiaCQ WangDD MrukHH Yan2006Dynamin II interacts with the cadherin- and occludin-based protein complexes at the blood-testis barrier in adult rat testes.J Endocrinol191571586

31. McNiven MA, Kim L, Krueger EW, Orth JD, Cao H, et al. (2000) Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol 151: 187–198.MA McNivenL. KimEW KruegerJD OrthH. Cao2000Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape.J Cell Biol151187198

32. Huang F, Goh LK, Sorkin A (2007) EGF receptor ubiquitination is not necessary for its internalization. Proc Natl Acad Sci U S A 104: 16904–16909.F. HuangLK GohA. Sorkin2007EGF receptor ubiquitination is not necessary for its internalization.Proc Natl Acad Sci U S A1041690416909

33. Lee JW, Juliano R (2004) Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 17: 188–202.JW LeeR. Juliano2004Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways.Mol Cells17188202

34. Jiang X, Huang F, Marusyk A, Sorkin A (2003) Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14: 858–870.X. JiangF. HuangA. MarusykA. Sorkin2003Grb2 regulates internalization of EGF receptors through clathrin-coated pits.Mol Biol Cell14858870

35. Bromann PA, Korkaya H, Courtneidge SA (2004) The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957–7968.PA BromannH. KorkayaSA Courtneidge2004The interplay between Src family kinases and receptor tyrosine kinases.Oncogene2379577968

36. Kaplan KB, Swedlow JR, Morgan DO, Varmus HE (1995) c-Src enhances the spreading of src−/− fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev 9: 1505–1517.KB KaplanJR SwedlowDO MorganHE Varmus1995c-Src enhances the spreading of src−/− fibroblasts on fibronectin by a kinase-independent mechanism.Genes Dev915051517

37. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, et al. (2003) Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci U S A 100: 13298–13302.EG Arias-SalgadoS. LizanoS. SarkarJS BruggeMH Ginsberg2003Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.Proc Natl Acad Sci U S A1001329813302

38. Burnham MR, Bruce-Staskal PJ, Harte MT, Weidow CL, Ma A, et al. (2000) Regulation of c-SRC activity and function by the adapter protein CAS. Mol Cell Biol 20: 5865–5878.MR BurnhamPJ Bruce-StaskalMT HarteCL WeidowA. Ma2000Regulation of c-SRC activity and function by the adapter protein CAS.Mol Cell Biol2058655878

39. Cao H, Chen J, Krueger EW, McNiven MA (2010) SRC-mediated phosphorylation of dynamin and cortactin regulates the “constitutive” endocytosis of transferrin. Mol Cell Biol 30: 781–792.H. CaoJ. ChenEW KruegerMA McNiven2010SRC-mediated phosphorylation of dynamin and cortactin regulates the “constitutive” endocytosis of transferrin.Mol Cell Biol30781792

40. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y (1999) Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 274: 1185–1188.S. AhnS. MaudsleyLM LuttrellRJ LefkowitzY. Daaka1999Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling.J Biol Chem27411851188

41. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, et al. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. Embo J 13: 3748–3756.R. SakaiA. IwamatsuN. HiranoS. OgawaT. Tanaka1994A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.Embo J1337483756

42. Kim W, Kook S, Kim DJ, Teodorof C, Song WK (2004) The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. J Biol Chem 279: 8333–8342.W. KimS. KookDJ KimC. TeodorofWK Song2004The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells.J Biol Chem27983338342

43. Kim W, Seok Kang Y, Soo Kim J, Shin NY, Hanks SK, et al. (2008) The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Mol Biol Cell 19: 2135–2146.W. KimY. Seok KangJ. Soo KimNY ShinSK Hanks2008The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling.Mol Biol Cell1921352146

44. Hamamura K, Furukawa K, Hayashi T, Hattori T, Nakano J, et al. (2005) Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci U S A 102: 11041–11046.K. HamamuraK. FurukawaT. HayashiT. HattoriJ. Nakano2005Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.Proc Natl Acad Sci U S A1021104111046

45. Kook S, Shim SR, Choi SJ, Ahnn J, Kim JI, et al. (2000) Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells. Mol Biol Cell 11: 929–939.S. KookSR ShimSJ ChoiJ. AhnnJI Kim2000Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells.Mol Biol Cell11929939

46. Wang Z, Zhang L, Yeung TK, Chen X (1999) Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol Biol Cell 10: 1621–1636.Z. WangL. ZhangTK YeungX. Chen1999Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.Mol Biol Cell1016211636